Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.02
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga
2026.11.02
10 Financials Stocks Moving In Monday's Pre-Market Session
Benzinga
2026.11.02
12 Information Technology Stocks Moving In Monday's Pre-Market Session
Benzinga
2026.11.02
12 Industrials Stocks Moving In Monday's Pre-Market Session
Benzinga
2026.11.02
Rapport Therapeutics Closes Underwritten Public Offerings Of 9,761,905 Shares At $21.00 Per Share
Benzinga
2026.11.02
Lumentum Holdings Q1 Adj. EPS $4.57 Beats $4.19 Estimate, Sales $1.263B Beat $1.249B Estimate
Benzinga
2026.11.02
Krystal Biotech Q3 EPS $2.05 Beats $1.77 Estimate, Sales $127.341M Beat $126.079M Estimate
Benzinga
2026.11.02
Tesla Rival NIO's October Deliveries Sink 15%
Benzinga
2026.11.02
Tower Semiconductor Sees Q4 Sales $570.000-$630.000 vs $574.727M Est
Benzinga
2026.11.02
Marriott Intl Q3 Adj. EPS $3.02 Beats $2.84 Estimate, Sales $7.005B Beat $6.920B Estimate
Benzinga
2026.11.02
Marriott International Raises FY2026 Adj EPS Guidance from $11.64-$11.81 to $12.07-$12.14 vs $11.73 Est
Benzinga
2026.11.02
Marriott International Sees Q4 Adj EPS $3.14-$3.21 vs $3.02 Est
Benzinga
2026.11.02
Axsome Therapeutics Q3 EPS $(0.25) Beats $(0.56) Estimate, Sales $259.691M Beat $249.929M Estimate
Benzinga
2026.11.02
Capital Power Q3 EPS $0.37 Misses $0.94 Estimate, Sales $831.000M Miss $1.032B Estimate
Benzinga
2026.11.02
Tempus AI Q3 Adj. EPS $0.07 Beats $(0.08) Estimate, Sales $411.537M Beat $409.350M Estimate
Benzinga
2026.11.02
Bitcoin Faces 3 Big Tests During the First Week of November
BeInCrypto
2026.11.02
Cipher Mining Q3 EPS $(0.22), Inline, Sales $26.701M Miss $38.473M Estimate
Benzinga
2026.11.02
Tempus AI Raises FY2026 Sales Guidance from $1.595B-$1.605B to $1.600B-$1.605B vs $1.592B Est
Benzinga
2026.11.02
Baird Maintains Neutral on Regeneron Pharmaceuticals, Raises Price Target to $875
Benzinga
2026.11.02
Tower Semiconductor Q3 Adj. EPS $1.15 Beats $1.08 Estimate, Sales $526.161M Beat $520.157M Estimate
Benzinga
2026.11.02
HC Wainwright & Co. Maintains Buy on Exelixis, Raises Price Target to $78
Benzinga
2026.11.02
Fort Technology Says The TSX Venture Exchange Has Approved Its Voluntary Delisting
Benzinga
2026.11.02
The GEO Group Says City Of Big Spring Enters Into 10-Yr Intergovernmental Service Agreement With US ICE For Activation Of Federal Immigration Processing Center At 2,329-Bed Big Spring Complex In Texas
Benzinga
2026.11.02
ParaZero Technologies Receives Fourth Order For Its DefendAir Net Pods From A European Defense Company; Terms Not Disclosed
Benzinga
2026.11.02
Eton Pharmaceutical Announces New Development Program ET-900 Evaluating Mecasermin Injection For Treatment Of Infantile And Epileptic Spasms; Plans To Dose First Patient In Q1 2027
Benzinga
2026.11.02
HC Wainwright & Co. Assumes Autolus Therapeutics at Buy, Announces Price Target of $10
Benzinga
2026.11.02
Baird Maintains Neutral on Mohawk Industries, Raises Price Target to $142
Benzinga
2026.11.02
Accendra Health Extends $150M Receivables Purchase Agreement To October 2029 With Its Size Unchanged
Benzinga
2026.11.02
Sinda Q3 EPS $(0.10) Misses $(0.07) Estimate
Benzinga
2026.11.02
Merck To Present New Data Across Its HIV Treatment And Prevention Pipeline And Portfolio At HIV Drug Therapy Glasgow 2026
Benzinga
1
...
341
342
343
344
345
346
...
712
>